Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simak Ali

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Nature Communications|March 14, 2024
High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug designVictoria I Cushing, Adrian F Koh, Junjie Feng, et al.
Breast Cancer Research and Treatment|March 13, 2015
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancerRezvan Abduljabbar, Ola H Negm, Chun-Fui Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2025
TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancerNuno Padrão, Sebastian Gregoricchio, Nils Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsJacqueline A Shaw, David S Guttery, Allison Hills, et al.
Elife|September 21, 2020
Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatmentsHajnalka L Pálinkás, Angéla Békési, Gergely Róna, et al.
Science Signaling|June 19, 2014
The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁Yichen Xu, Hua Zhang, Lei C Lit, et al.
Molecular Cell|November 17, 2023
Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibitionGemma A Wilson, Karla Vuina, Georgina Sava, et al.
Oncogene|November 24, 2023
Selective inhibition of CDK9 in triple negative breast cancerEbtihal H Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, et al.
The Lancet. Oncology|June 1, 2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.
Anti-Cancer Drugs|December 13, 2024
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancerCaroline H Rinderle, Christopher V Baker, Courtney B Lagarde, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Nature Communications|March 14, 2024
High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug designVictoria I Cushing, Adrian F Koh, Junjie Feng, et al.
Breast Cancer Research and Treatment|March 13, 2015
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancerRezvan Abduljabbar, Ola H Negm, Chun-Fui Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2025
TRIM24 as a therapeutic target in endocrine treatment-resistant breast cancerNuno Padrão, Sebastian Gregoricchio, Nils Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell CountsJacqueline A Shaw, David S Guttery, Allison Hills, et al.
Elife|September 21, 2020
Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatmentsHajnalka L Pálinkás, Angéla Békési, Gergely Róna, et al.
Science Signaling|June 19, 2014
The kinase LMTK3 promotes invasion in breast cancer through GRB2-mediated induction of integrin β₁Yichen Xu, Hua Zhang, Lei C Lit, et al.
Molecular Cell|November 17, 2023
Active growth signaling promotes senescence and cancer cell sensitivity to CDK7 inhibitionGemma A Wilson, Karla Vuina, Georgina Sava, et al.
Oncogene|November 24, 2023
Selective inhibition of CDK9 in triple negative breast cancerEbtihal H Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, et al.
The Lancet. Oncology|June 1, 2005
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trialAndreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, et al.
Anti-Cancer Drugs|December 13, 2024
Screening of a kinase inhibitor library identified novel targetable kinase pathways in triple-negative breast cancerCaroline H Rinderle, Christopher V Baker, Courtney B Lagarde, et al.
Pageof 12